Research Topics
Species | Jostein DahleSummaryAffiliation: Institute for Cancer Research Country: Norway Publications
| Collaborators
|
Detail Information
Publications
Overexpression of human OGG1 in mammalian cells decreases ultraviolet A induced mutagenesisJostein Dahle
Department of Radiation Biology, The Norwegian Radium Hospital, 0310 Oslo, Norway
Cancer Lett 267:18-25. 2008..The results suggest a link between the 8-oxoG lesion and UVA-induced mutagenesis. We propose that hOGG1 has a role in maintaining genomic stability in mammalian cells after oxidative stress...
A one-step method for determining the maximum number of bound antibodies, and the affinity and association rate constants for antibody bindingJostein Dahle
Department of Radiation Biology, Institute for Cancer Research, The Norwegian Radium Hospital, Oslo, Norway
Nucl Med Commun 28:742-7. 2007..The on and off rate constants are determined by kinetic binding experiments. However, it is necessary to perform two to three different types of experiment in order to determine these parameters...
Targeted cancer therapy with a novel low-dose rate alpha-emitting radioimmunoconjugateJostein Dahle
Department of Radiation Biology, Norwegian Radium Hospital, Oslo, Norway
Blood 110:2049-56. 2007..Thorium-227 based constructs may provide a novel approach for targeted therapy against a wide variety of cancers...
Assessment of long-term radiotoxicity after treatment with the low-dose-rate alpha-particle-emitting radioimmunoconjugate (227)Th-rituximabJostein Dahle
Department of Radiation Biology, The Norwegian Radium Hospital, Oslo University Hospital, 0310 Oslo, Norway
Eur J Nucl Med Mol Imaging 37:93-102. 2010..To evaluate possible late side effects of (227)Th-rituximab, the long-term radiotoxicity of this potential radiopharmaceutical was investigated...
In vitro cytotoxicity of low-dose-rate radioimmunotherapy by the alpha-emitting radioimmunoconjugate Thorium-227-DOTA-rituximabJostein Dahle
Department of Radiation Biology, Norwegian Radium Hospital, Montebello, Oslo, Norway
Int J Radiat Oncol Biol Phys 75:886-95. 2009....
Dosimetry of a 238Pu-based alpha-particle irradiator and its biological application in a study of the bystander effectJostein Dahle
Department of Radiation Biology, Oslo University Hospital, Oslo, Norway
Anticancer Res 31:2113-20. 2011..In conclusion, the broad-beam α-particle irradiator improved in this study represents a useful tool in the investigation of direct and non-targeted effects of α-particle radiation...
Toxicity and relative biological effectiveness of alpha emitting radioimmunoconjugatesJostein Dahle
Department of Radiation Biology, Institute for Cancer Research, Oslo University Hospital, Montebello, 0310 Oslo, Norway
Curr Radiopharm 4:321-8. 2011..This review will provide a brief overview of the most promising radionuclides for targeted α-therapy and compare their relative biological effectiveness (RBE) and normal tissue toxicity...
Relative biologic effects of low-dose-rate alpha-emitting 227Th-rituximab and beta-emitting 90Y-tiuexetan-ibritumomab versus external beam X-radiationJostein Dahle
Department of Radiation Biology, The Norwegian Radium Hospital, Montebello, Oslo, Norway
Int J Radiat Oncol Biol Phys 72:186-92. 2008..To determine the relative biologic effects (RBE) of alpha-particle radiation from 227Th-rituximab and of beta-radiation from 90Y-tiuexetan-ibritumomab (Zevalin) compared with external beam X-radiation in the Raji lymphoma xenograft model...
Initial evaluation of (227)Th-p-benzyl-DOTA-rituximab for low-dose rate alpha-particle radioimmunotherapyJostein Dahle
Department of Radiation Biology, Rikshospitalet Radiumhospitalet HE, Montebello, 0310 Oslo, Norway
Nucl Med Biol 33:271-9. 2006..4 days. Incubation of lymphoma cells with (227)Th-DOTA-p-benzyl-rituximab resulted in a significant antigen-dependent inhibition of cell growth. The data presented here warrant further studies of (227)Th-DOTA-p-benzyl-rituximab...
Evaluation of the binding of radiolabeled rituximab to CD20-positive lymphoma cells: an in vitro feasibility study concerning low-dose-rate radioimmunotherapy with the alpha-emitter 227ThKatrine B Melhus
Department of Radiation Biology, Institute for Cancer Research, The Norwegian Radium Hospital, Montebello, Oslo, Norway
Cancer Biother Radiopharm 22:469-79. 2007..These results were confirmed using flow cytometry. Rituximab was found to be localized in patches on the cell membrane. The findings indicated that 227Th-labeled rituximab has relevant antigen-targeting properties for radioimmunotherapy...
Treatment of HER2-expressing breast cancer and ovarian cancer cells with alpha particle-emitting 227Th-trastuzumabHelen Heyerdahl
Department of Radiation Biology, Institute for Cancer Research, Oslo University Hospital, Montebello, Oslo, Norway
Int J Radiat Oncol Biol Phys 79:563-70. 2011....
Bystander effects may modulate ultraviolet A and B radiation-induced delayed mutagenesisJostein Dahle
Department of Radiation Biology, The Norwegian Radium Hospital, Montebello, 0310 Oslo, Norway
Radiat Res 163:289-95. 2005..In conclusion, the results suggest that a bystander effect is involved in ultraviolet-radiation-induced genomic instability and that it may be mediated in part by gap junctional intercellular communication...
Preparation of TH227-labeled radioimmunoconjugates, assessment of serum stability and antigen binding abilityRoy H Larsen
Department of Radiation Biology, University of Oslo and The Norwegian Radium Hospital, Oslo, Norway
Cancer Biother Radiopharm 22:431-7. 2007..The overall labeling yield spanned from 6% to 17%. The radioimmunoconjugates demonstrated a relevant stability in serum and showed appropriate antigen-binding abilities...
Transcriptional responses in irradiated and bystander fibroblasts after low dose α-particle radiationErta Kalanxhi
Department of Radiation Biology, Oslo University Hospital, Institute for Cancer Research, Oslo, Norway
Int J Radiat Biol 88:713-9. 2012....
Fractionated therapy of HER2-expressing breast and ovarian cancer xenografts in mice with targeted alpha emitting 227Th-DOTA-p-benzyl-trastuzumabHelen Heyerdahl
Department of Radiation Biology, Institute for Cancer Research, Oslo University, Hospital The Norwegian Radium Hospital, Oslo, Norway
PLoS ONE 7:e42345. 2012....
The pheomelanin precursor 5-S-cysteinyldopa protects melanocytes from membrane damage induced by ultraviolet A radiationEgil Kvam
Department of Radiation Biology, The Norwegian Radium Hospital, Montebello, 0310 Oslo, Norway
Cancer Lett 221:131-4. 2005..Thus, 5-S-cysteinyldopa, may at the same time sensitise DNA and protect membranes from damage induced by ultraviolet radiation...
A (238)Pu irradiator for exposure of cultured cells with alpha-radiation: construction, calibration and dosimetryNikolai Tisnek
Department of Radiation Biology, The Norwegian Radium Hospital, Oslo, Norway
Appl Radiat Isot 67:1998-2002. 2009..2 Gy/s. The (238)Pu alpha-particle irradiator is feasible for irradiation of cells and it can be used for studies of both direct effects and bystander effects of alpha-radiation...
The role of serotonin and p53 status in the radiation-induced bystander effectErta Kalanxhi
Department of Radiation Biology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway
Int J Radiat Biol 88:773-6. 2012..The aim of this study was to investigate the role of serotonin and protein 53 (p53) status of the cells in the radiation-induced bystander effects (RIBE)...
Preclinical evaluation of 227Th-labeled and 177Lu-labeled trastuzumab in mice with HER-2-positive ovarian cancer xenograftsNasir Abbas
Department of Radiation Biology, Norwegian Radium Hospital, Oslo, Norway
Nucl Med Commun 33:838-47. 2012....
Genome-wide microarray analysis of human fibroblasts in response to γ radiation and the radiation-induced bystander effectErta Kalanxhi
Department of Radiation Biology, Institute for Cancer Research, Oslo University Hospital, Montebello 0310 Oslo, Norway
Radiat Res 177:35-43. 2012..A set of 14 genes, many of which were regulated by p53, were found to be induced early after irradiation (prior to medium transfer) and may be important in the generation or propagation of the bystander effect...
Experimental α-particle radioimmunotherapy of breast cancer using 227Th-labeled p-benzyl-DOTA-trastuzumabNasir Abbas
Department of Radiation Biology, Institute for Cancer Research, Oslo University Hospital, Montebello, 0310 Oslo, Norway
EJNMMI Res 1:18. 2011..abstract:..
Multiplex polymerase chain reaction analysis of UV-A- and UV-B-induced delayed and early mutations in V79 Chinese hamster cellsJostein Dahle
Department of Radiation Biology, The Norwegian Radium Hospital, Montebello, 0310 Oslo, Norway
Photochem Photobiol 81:114-9. 2005..Therefore, the present results support the hypothesis that persistent increase in oxidative stress is involved in the mechanism of UV-induced genomic instability...
Induction of delayed mutations and chromosomal instability in fibroblasts after UVA-, UVB-, and X-radiationJostein Dahle
Department of Biophysics, The Norwegian Radium Hospital, Montebello, 0310 Oslo, Norway
Cancer Res 63:1464-9. 2003..Thus, the mechanism of UVA-induced chromosomal instability is apparently different from that of UVB and X-radiation...
Automated counting of mammalian cell colonies by means of a flat bed scanner and image processingJostein Dahle
Department of Radiation Biology, Norwegian Radium Hospital, Montebello, Oslo, Norway
Cytometry A 60:182-8. 2004..However, several commercial automatic colony counters are available. Based on CCD video imaging and image analysis they are relatively expensive and can analyze only one petri dish at a time...
Increased level of oxidative stress in genomically unstable cell clonesJostein Dahle
Department of Biophysics, The Norwegian Radium Hospital, Montebello, 0310 Oslo, Norway
J Photochem Photobiol B 74:23-8. 2004..The unstable clones had elevated levels of oxidants, supporting the hypothesis that intermediate reactive oxygen species might have a role in the maintenance of genomic instability induced by ultraviolet radiation...
Pigmented melanocytes are protected against ultraviolet-A-induced membrane damageEgil Kvam
Department of Biophysics, The Norwegian Radium Hospital, Montebello, 0310 Oslo, Norway
J Invest Dermatol 121:564-9. 2003..Thus, pigmented melanocytes apparently contain antioxidants more potent than glutathione, protecting them from ultraviolet-A-induced membrane damage...
Melanin synthesis may sensitize melanocytes to oxidative DNA damage by ultraviolet A radiation and protect melanocytes from direct DNA damage by ultraviolet B radiationEgil Kvam
Pigment Cell Res 17:549-50. 2004
